DEZIMA PHARMA B.V.
4Patents
4Active
4Granted
45Portfolio score
Filing activity: Feb 5, 2014 → Apr 9, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10300059B2 | Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and HMG CoA reductase inhibitors | Human Necessities | 6 | Active |
| US11013742B2 | Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases | Human Necessities | 4 | Active |
| US10653692B2 | Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases | Human Necessities | 4 | Active |
| US10112904B2 | Process for preparing synthetic intermediates for preparing tetrahydroquinoline derivatives | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.